APPENDIX 2

WITNESSES WHO APPEARED BEFORE THE COMMITTEE

Canberra, 28April 2011

CLARK, Dr Julian, Head of Business Development, Walter and Eliza Hall Institute of Medical Research

CROSS, Dr Martin, Chairman, Generic Medicines Industry Association

DAVIES, Dr Trevor, Councillor, Institute of Patent and Trade Mark Attorneys

DRAHOS, Professor Peter, Director, Centre for Governance of Knowledge and Development, Australian National University

HAMER, Mr Richard, Deputy Chairman, Intellectual Property Committee, Business Law Section, Law Council of Australia

HANNAH, Mr Colin, Vice President, Australia and New Zealand, Hospira Pty Ltd; Board Member, Generic Medicines Industry Association

HILTON, Professor Douglas, Director, Walter and Eliza Hall Institute of Medical Research

JARVIS, Mr Richard, Member, Intellectual Property Committee, Law Council of Australia

LIDDICOAT, Mr Johnathon, Private capacity

LOFTHOUSE, Dr Shari, Manager of Intellectual Property and Development and Acting Director of Commercialisation, Peter MacCullum Cancer Centre

MITCHELL, Dr Gillian, Clinical Oncologist and Director, Familial Cancer Centre, Peter MacCallum Cancer Centre

MONK, Ms Deborah, Director, Innovation and Industry Policy, Medicines Australia

MURPHY, Mr Tim, Co-Chair, Innovation Strategic Committee, Medicines Australia; Head, Government Affairs and Policy, GlaxoSmithKline Australia

NICOL, Professor Dianne, Private capacity

OBRANOVICH, Dr Tania, Fellow, Institute of Patent and Trade Mark Attorneys

OLVER, Professor Ian, Chief Executive Officer, Cancer Council Australia

SHAW, Dr Brendan, Chief Executive, Medicines Australia

SUTHERS, Dr Graeme, Chair, Genetics Advisory Committee, Royal College of Pathologists of Australasia

Canberra, 29 April 2011

BEATTIE, Mrs Fatima, Deputy Director-General, IP Australia

CHRISTIE, Professor Andrew, Private capacity

COSSEY, Mr Matthew, Chief Executive Officer, CropLife Australia

HALTON, Ms Jane, Secretary, Department of Health and Ageing

LAVELLE, Dr Anna, Chief Executive Officer, AusBiotech

LUNN, Mr Peter, Manager, Pharmaceuticals and Health Technologies Section, Department of Innovation, Industry, Science and Research

McDONALD, Ms Mary, First Assistant Secretary, Regulatory Policy and Governance Division, Department of Health and Ageing

MOORE, Ms Terry, Director, Domestic Policy, IP Australia

PALOMBI, Dr Luigi, Private capacity

PETERS, Dr Kirrily, Manager, Pharmaceuticals Industry Strategy and Environment Section, Department of Innovation, Industry, Science and Research

PRESS, Ms Lexie, Examiner of Patents, IP Australia

QUINN, Mr Daniel, Policy Manager, Biotechnology, and Policy Manager, Minor Use, CropLife Australia

REID, Mr Chris, General Counsel, Department of Health and Ageing